Summary of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2014

Accounting Policies [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]

as filed on our Form 10-K/A on September 19, 2014, we also restated our December 31, 2013 Balance Sheet as it pertains to the Fair Value of our Warrants, Preferred Series C & D and Convertible Debentures to amounts as stated below from how they were reported as of December 31, 2013 in our 10-K (in thousands): 

	December 31, 2013 (as previously reported)		Adjustments		December 31, 2013 (Restated)
Derivative Financial Instruments – warrants	$	684	$	(64)	$	620
Derivative Financial Instruments – Series C and D PS and DP	$	23,606	$	(23,310)	$	296
Debentures payable – carried at fair value	$	257,451	$	(219,201)	$	38,250
Total Liabilities	$	284,576	$	(242,575)	$	42,001
Accumulated Deficit	$	(479,485)	$	242,575	$	(236,910)
Total shareholders’ deficit	$	(284,435)	$	242,575	$	(41,860)

Schedule of Derivative Instruments [Table Text Block]

The tables below reflect the changes in restating the derivative liabilities for the three months and nine months ended September 30, 2013:

Derivative Liability Restatement for the 3 months ended September 30, 2013 (in thousands):

	3 Mos. September 30, 2013 (as previously reported)		Adjustments		3 Mos. September 30, 2013 (as Restated)
Gain (loss) from change in fair value of hybrid financial instruments	$	(24,165)	$	28,660	$	4,495
Gain (loss) from change in fair value of derivative liability – warrants	$	92	$	(2)	$	90
Gain (loss) from change in fair value of derivative liability – Series C & D	$	(2,620)	$	2,651	$	31
Net income (loss)	$	(26,200)	$	31,309	$	5,109
Net income (loss) available to shareholders	$	(26,245)	$	31,309	$	5,064
Comprehensive income (loss)	$	(26,200)	$	31,309	$	5,109

Derivative Liability Restatement for the 9 months ended September 30, 2013 (in thousands):

	9 Mos. September 30, 2013 (as previously reported)		Adjustments		9 Mos. September 30, 2013 (as Restated)
Gain (loss) from change in fair value of hybrid financial instruments	$	(46,959)	$	75,508	$	28,549
Gain (loss) from change in fair value of derivative liability – warrants	$	3,503	$	11	$	3,514
Gain (loss) from change in fair value of derivative liability – Series C & D	$	(4,769)	$	6,798	$	2,029
Net income (loss)	$	(47,534)	$	82,317	$	34,783
Net income available to shareholders	$	(48,276)	$	82,317	$	34,041
Comprehensive income (loss)	$	(47,667)	$	82,583	$	34,916

Schedule of Derivative Instruments in Statement of Cash Flows, Fair Value [Table Text Block]

Statement of Cash Flows for the 9 months ended September 30, 2013 (in thousands):

	9 Mos. September 30, 2013 (as previously reported)		Adjustments		9 Mos. September 30, 2013 (as Restated)
Net income (loss)	$	(47,534)	$	82,317	$	34,783
Gain (loss) from change in fair value of hybrid financial instruments	$	(46,959)	$	75,508	$	28,549
Gain (loss) from change in fair value of derivative liability – warrants	$	3,503	$	11	$	3,514
Gain (loss) from change in fair value of derivative liability – Series C & D	$	(4,769)	$	6,798	$	2,029
Net cash used in operating activities	$	(536)	$	-	$	(536)

Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]

The components of basic and diluted income (loss) per share attributable to NeoMedia Technologies, Inc. common stock shareholders were as follows (in thousands, except share and per share data):

	Three Months Ended  September 30,				Nine Months Ended  September 30,
	2014		2013		2014		2013
			(restated)				(restated)
Numerator:
Net income (loss) available to common shareholders	$	(1,088)	$	5,064	$	2,500	$	34,041
Effect of dilutive securities
Hybrid financial instruments		-		261		-		24,314
Derivative liability - warrants		-		90		-		3,514
Derivative liability - Series C and D preferred stock and debentures		-		31		-		2,029
Numerator for diluted income (loss) per common share	$	(1,088)	$	5,446	$	2,500	$	63,898
Denominator:
Weighted average shares used to compute basic income (loss) per common share		1,357,349,653		4,984,827,279		810,443,147		3,823,483,604
Effect of dilutive securities:
Hybrid financial instruments		-		32,949,714		32,949,714		32,949,714
Derivative liability - warrants		-		2,083,292		2,083,292		2,083,292
Derivative liability - Series C and D preferred stock and debentures		-		3,398,694		3,398,694		3,398,694
Denominator for diluted income (loss) per common share		1,357,349,653		5,023,258,979		848,874,847		3,861,915,304
Basic income (loss) per common share	$	.00	$	0.00	$	0.00	$	0.00
Diluted income (loss) per common share	$	.00	$	0.00	$	0.00	$	0.00